Table 3.
Baseline characteristics and outcomes of the included studies (n = 28).
| Study [Ref.]/Year | Region | Sampling techniques | Study area | Study subjects | Sample Size, n | P% (IDF) | P% (NCEP/ATPIII) | Quality score by JBI criteria |
|---|---|---|---|---|---|---|---|---|
| Berhan et al. [57]/2012 | Oromia | MPSSS | Jimma | HIV on HAART | 313 | — | 21.1 | Good |
| Mossie et al. [36]/2016 | Oromia | MPSSS | Jimma | Working adults | 1316 | 16.7 | 10.5 | Good |
| Tachebele et al. [37]/2014 | Amhara | SRST | Gondar | Hypertensive | 300 | 39.3 | 40.7 | Good |
| Tadewos et al. [58]/2018 | SNNP | SRST | Hawassa | Hypertensive | 238 | — | 48.7 | Good |
| Woyesa et al. [59]/2017 | SNNP | SRST | Hawassa | T2DM patients | 314 | — | 70.1 | Good |
| Bosho et al. [38]/2018 | Oromia | SRST | Jimma | HIV on HAART | 268 | 20.5 | 23.5 | Good |
| Hirigo et al. [39]/2016 | SNNP | NA | Hawassa | HIV on HAART | 185 | 24.3 | 17.8 | Good |
| Tran et al. [40]/2011 | Addis Ababa | MPSSS | Addis Ababa | Working adults | 1935 | 17.9 | 12.5 | Good |
| Abda et al. [60]/2016 | Oromia | CST | Jimma | Working adults | 225 | — | 26 | Good |
| Tadewos et al. [61]/2017 | SNNP | SRST | Hawassa | T2DM patients | 270 | — | 45.9 | Good |
| Tesfaye et al. [41]/2014 | SNNP | SRST | Hawassa | HIV on HAART | 188 | 25 | 18.1 | Good |
| Biadgo et al. [42]/2018 | Amhara | SRST | Gondar | T2DM patients | 159 | 53.5 | 66.7 | Good |
| Birarra et al. [43]/2018 | Amhara | SRST | Gondar | T2DM patients | 256 | 57 | 70.3 | Good |
| Solomon et al. [44]/2020 | Addis Ababa | NA | Addis Ababa | Working adults | 325 | 8.6 | 20.3 | Good |
| Gebremeskel et al. [45]/2019 | Tigray | SRST | Mekele | T2DM patients | 419 | 51.1 | — | Good |
| Bune et al. [46]/2020 | SNNP | SRST | Gedeo zone | HIV on HAART | 422 | 22 | — | Good |
| Gebremariam et al. [47]/2020 | Tigray | Survey | Mekele | Working adults | 1380 | 40.7 | — | Good |
| Asaye et al. [48]/2020 | Oromia | CST | Jimma | Psychiatric patients | 360 | 28.9 | 22.2 | Good |
| Wube et al. [49]/2019 | SNNP | SRST | Hawassa | T2DM patients | 314 | 52.9 | 70.1 | Good |
| Teshome et al. [50]/2020 | SNNP | SRST | Hawassa | Psychiatric patients | 245 | 26.9 | 24.5 | Good |
| Zerga et al. [62]/2020 | Amhara | CST | Desie | T2DM patients | 330 | - | 59.4 | Good |
| Gebreyes et al. [51]/2018 | All regions | NA | — | Working adults | 8673 | 4.8 | — | Good |
| KerieS et al. [52]/2019 | SNNP | SRST | Mizan-Aman | Working adults | 534 | 9.6 | — | Good |
| Gebrehiwot et al. [53]/2020 | Tigray | SRST | Mekele | Working adults | 266 | 21.8 | — | Good |
| Ataro et al. [54]/2020 | Eastern Ethiopia | CST | Harar | HIV on HAART | 375 | 26.7 | 22.1 | Good |
| Cheneke et al. [63]/2019 | Eastern Ethiopia | CST | Harar | Working adults | 365 | - | 27.7 | Good |
| Melak et al. [55]/2016 | Amhara | SRST | Gondar | Working adults | 227 | 13.6 | — | Good |
| Geto et al. [56]/2018 | Addis Ababa | CST | Addis Ababa | Working adults | 450 | 27.6 | 16.7 | Good |
NCEP/ATPIII, National Cholesterol Education Program–Adult Treatment Panel III; IDF, International Diabetes Federation; T2DM, type 2 diabetes mellitus; MPSSS, multistage probabilistic stratified sampling strategy; SRST, simple/systematic random sampling technique; CST, consecutive sampling technique; SNNP, South Nation Nationality and People; HAART, highly active antiretroviral therapy; JBI, Joanna Brigg's Institute quality appraisal.